Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 18 de 18
Filter
Add more filters










Publication year range
1.
mBio ; 7(4)2016 08 16.
Article in English | MEDLINE | ID: mdl-27531908

ABSTRACT

UNLABELLED: Staphylococcus aureus is a leading cause of life-threatening infections worldwide. The MIC of an antibiotic against S. aureus, as well as other microbes, is determined by the affinity of the antibiotic for its target in addition to a complex interplay of many other cellular factors. Identifying nontarget factors impacting resistance to multiple antibiotics could inform the design of new compounds and lead to more-effective antimicrobial strategies. We examined large collections of transposon insertion mutants in S. aureus using transposon sequencing (Tn-Seq) to detect transposon mutants with reduced fitness in the presence of six clinically important antibiotics-ciprofloxacin, daptomycin, gentamicin, linezolid, oxacillin, and vancomycin. This approach allowed us to assess the relative fitness of many mutants simultaneously within these libraries. We identified pathways/genes previously known to be involved in resistance to individual antibiotics, including graRS and vraFG (graRS/vraFG), mprF, and fmtA, validating the approach, and found several to be important across multiple classes of antibiotics. We also identified two new, previously uncharacterized genes, SAOUHSC_01025 and SAOUHSC_01050, encoding polytopic membrane proteins, as important in limiting the effectiveness of multiple antibiotics. Machine learning identified similarities in the fitness profiles of graXRS/vraFG, SAOUHSC_01025, and SAOUHSC_01050 mutants upon antibiotic treatment, connecting these genes of unknown function to modulation of crucial cell envelope properties. Therapeutic strategies that combine a known antibiotic with a compound that targets these or other intrinsic resistance factors may be of value for enhancing the activity of existing antibiotics for treating otherwise-resistant S. aureus strains. IMPORTANCE: Bacterial resistance to every major class of antibiotics has emerged, and we are entering a "post-antibiotic era" where relatively minor infections can lead to serious complications or even death. The utility of an antibiotic for a specific pathogen is limited by both intrinsic and acquired factors. Identifying the repertoire of intrinsic resistance factors of an antibiotic for Staphylococcus aureus, a leading cause of community- and hospital-acquired infections, would inform the design of new drugs as well as the identification of compounds that enhance the activity of existing drugs. To identify factors that limit the activity of antibiotics against S. aureus, we used Tn-Seq to simultaneously assess fitness of transposon mutants in every nonessential gene in the presence of six clinically important antibiotics. This work provides an efficient approach for identifying promising targets for drugs that can enhance susceptibility or restore sensitivity to existing antibiotics.


Subject(s)
Anti-Bacterial Agents/pharmacology , Gene Knockout Techniques , Genes, Bacterial , Mutagenesis, Insertional , Staphylococcus aureus/drug effects , Staphylococcus aureus/genetics , DNA Transposable Elements , Gene Library , Microbial Sensitivity Tests
2.
Pathog Dis ; 74(4): ftw031, 2016 Jun.
Article in English | MEDLINE | ID: mdl-27073254

ABSTRACT

A large percentage of Pseudomonas aeruginosa clinical isolates have been noted to be resistant to carbapenems due to loss of function of the OprD porin, the primary mechanism of entry for carbapenems. Such modifications also substantially abolish the organism's ability to transport arginine. Here we report the identification of an in-frame deletion in oprD which confers carbapenem resistance but is expressed and retains the ability to transport arginine.


Subject(s)
Porins/genetics , Pseudomonas Infections/microbiology , Pseudomonas aeruginosa/genetics , Sequence Deletion , Amino Acid Sequence , Humans , Models, Molecular , Porins/chemistry , Protein Conformation , Pseudomonas aeruginosa/isolation & purification , Reading Frames
3.
Antimicrob Agents Chemother ; 60(6): 3856-61, 2016 06.
Article in English | MEDLINE | ID: mdl-27067331

ABSTRACT

Ceftazidime is one of the few cephalosporins with activity against Pseudomonas aeruginosa Using whole-genome comparative analysis, we set out to determine the prevalent mechanism(s) of resistance to ceftazidime (CAZ) using a set of 181 clinical isolates. These isolates represented various multilocus sequence types that consisted of both ceftazidime-susceptible and -resistant populations. A presumptive resistance mechanism against ceftazidime was identified in 88% of the nonsusceptible isolates using this approach.


Subject(s)
Bacterial Proteins/genetics , Gene Expression Regulation, Bacterial , Genome, Bacterial , N-Acetylmuramoyl-L-alanine Amidase/genetics , Pseudomonas aeruginosa/genetics , beta-Lactam Resistance/genetics , beta-Lactamases/genetics , Amino Acid Sequence , Anti-Bacterial Agents/pharmacology , Ceftazidime/pharmacology , Citrobacter freundii/genetics , Genotype , Humans , Microbial Sensitivity Tests , Multilocus Sequence Typing , Pseudomonas Infections/microbiology , Pseudomonas aeruginosa/drug effects , Pseudomonas aeruginosa/growth & development , Pseudomonas aeruginosa/isolation & purification , Sequence Alignment
4.
mBio ; 7(2): e02162, 2016 Mar 22.
Article in English | MEDLINE | ID: mdl-27006459

ABSTRACT

UNLABELLED: Escherichia colisequence type 131 (ST131) has emerged globally as the most predominant extraintestinal pathogenic lineage within this clinically important species, and its association with fluoroquinolone and extended-spectrum cephalosporin resistance impacts significantly on treatment. The evolutionary histories of this lineage, and of important antimicrobial resistance elements within it, remain unclearly defined. This study of the largest worldwide collection (n= 215) of sequenced ST131E. coliisolates to date demonstrates that the clonal expansion of two previously recognized antimicrobial-resistant clades, C1/H30R and C2/H30Rx, started around 25 years ago, consistent with the widespread introduction of fluoroquinolones and extended-spectrum cephalosporins in clinical medicine. These two clades appear to have emerged in the United States, with the expansion of the C2/H30Rx clade driven by the acquisition of ablaCTX-M-15-containing IncFII-like plasmid that has subsequently undergone extensive rearrangement. Several other evolutionary processes influencing the trajectory of this drug-resistant lineage are described, including sporadic acquisitions of CTX-M resistance plasmids and chromosomal integration ofblaCTX-Mwithin subclusters followed by vertical evolution. These processes are also occurring for another family of CTX-M gene variants more recently observed among ST131, theblaCTX-M-14/14-likegroup. The complexity of the evolutionary history of ST131 has important implications for antimicrobial resistance surveillance, epidemiological analysis, and control of emerging clinical lineages ofE. coli These data also highlight the global imperative to reduce specific antibiotic selection pressures and demonstrate the important and varied roles played by plasmids and other mobile genetic elements in the perpetuation of antimicrobial resistance within lineages. IMPORTANCE: Escherichia coli, perennially a major bacterial pathogen, is becoming increasingly difficult to manage due to emerging resistance to all preferred antimicrobials. Resistance is concentrated within specificE. colilineages, such as sequence type 131 (ST131). Clarification of the genetic basis for clonally associated resistance is key to devising intervention strategies. We used high-resolution genomic analysis of a large global collection of ST131 isolates to define the evolutionary history of extended-spectrum beta-lactamase production in ST131. We documented diverse contributory genetic processes, including stable chromosomal integrations of resistance genes, persistence and evolution of mobile resistance elements within sublineages, and sporadic acquisition of different resistance elements. Both global distribution and regional segregation were evident. The diversity of resistance element acquisition and propagation within ST131 indicates a need for control and surveillance strategies that target both bacterial strains and mobile genetic elements.


Subject(s)
Epidemics , Escherichia coli Infections/epidemiology , Escherichia coli Infections/microbiology , Escherichia coli/genetics , Evolution, Molecular , Genotype , Chromosomes, Bacterial , Drug Resistance, Bacterial , Escherichia coli/classification , Escherichia coli/isolation & purification , Genes, Bacterial , Global Health , Humans , Molecular Epidemiology , Plasmids , Sequence Analysis, DNA
5.
Antimicrob Agents Chemother ; 59(1): 427-36, 2015 Jan.
Article in English | MEDLINE | ID: mdl-25367914

ABSTRACT

Many clinical isolates of Pseudomonas aeruginosa cause infections that are difficult to eradicate due to their resistance to a wide variety of antibiotics. Key genetic determinants of resistance were identified through genome sequences of 390 clinical isolates of P. aeruginosa, obtained from diverse geographic locations collected between 2003 and 2012 and were related to microbiological susceptibility data for meropenem, levofloxacin, and amikacin. ß-Lactamases and integron cassette arrangements were enriched in the established multidrug-resistant lineages of sequence types ST111 (predominantly O12) and ST235 (O11). This study demonstrates the utility of next-generation sequencing (NGS) in defining relevant resistance elements and highlights the diversity of resistance determinants within P. aeruginosa. This information is valuable in furthering the design of diagnostics and therapeutics for the treatment of P. aeruginosa infections.


Subject(s)
Amikacin/pharmacology , Anti-Bacterial Agents/pharmacology , Levofloxacin/pharmacology , Pseudomonas aeruginosa/drug effects , Thienamycins/pharmacology , Amikacin/therapeutic use , Anti-Bacterial Agents/therapeutic use , Bacterial Typing Techniques , Base Sequence , DNA, Bacterial/genetics , Drug Resistance, Multiple, Bacterial/genetics , Genome, Bacterial/genetics , Humans , Levofloxacin/therapeutic use , Meropenem , Microbial Sensitivity Tests , Multilocus Sequence Typing , Pseudomonas Infections/drug therapy , Pseudomonas Infections/microbiology , Pseudomonas aeruginosa/genetics , Pseudomonas aeruginosa/isolation & purification , Sequence Analysis, DNA , Thienamycins/therapeutic use , beta-Lactamases/genetics
6.
mBio ; 5(5): e01729-14, 2014 Sep 02.
Article in English | MEDLINE | ID: mdl-25182329

ABSTRACT

UNLABELLED: Staphylococcus aureus is a leading cause of both community- and hospital-acquired infections that are increasingly antibiotic resistant. The emergence of S. aureus resistance to even last-line antibiotics heightens the need for the development of new drugs with novel targets. We generated a highly saturated transposon insertion mutant library in the genome of S. aureus and used Tn-seq analysis to probe the entire genome, with unprecedented resolution and sensitivity, for genes of importance in infection. We further identified genes contributing to fitness in various infected compartments (blood and ocular fluids) and compared them to genes required for growth in rich medium. This resulted in the identification of 426 genes that were important for S. aureus fitness during growth in infection models, including 71 genes that could be considered essential for survival specifically during infection. These findings highlight novel as well as previously known genes encoding virulence traits and metabolic pathways important for S. aureus proliferation at sites of infection, which may represent new therapeutic targets. IMPORTANCE: Staphylococcus aureus continues to be a leading cause of antibiotic-resistant community and nosocomial infection. With the bacterium's acquisition of resistance to methicillin and, more recently, vancomycin, the need for the development of new drugs with novel targets is urgent. Applying a highly saturated Tn-seq mutant library to analyze fitness and growth requirements in a murine abscess and in various infection-relevant fluids, we identified S. aureus traits that enable it to survive and proliferate during infection. This identifies potential new targeting opportunities for the development of novel therapeutics.


Subject(s)
Abscess/microbiology , Genome, Bacterial , Staphylococcal Infections/microbiology , Staphylococcus aureus/genetics , Animals , Anti-Bacterial Agents/pharmacology , Bacterial Proteins/genetics , Computational Biology , DNA Transposable Elements/genetics , Drug Resistance, Bacterial , Gene Library , Male , Mice , RNA, Antisense/genetics , Sequence Analysis, DNA , Virulence Factors/genetics
7.
J Antimicrob Chemother ; 69(8): 2065-75, 2014 Aug.
Article in English | MEDLINE | ID: mdl-24777906

ABSTRACT

OBJECTIVES: Ceftaroline, approved in Europe in 2012, has activity against methicillin-resistant Staphylococcus aureus (MRSA), with MIC90 values of 1-2 mg/L depending on geographical location. During a global 2010 surveillance programme, conducted prior to the European launch, 4 S. aureus isolates, out of 8037 tested, possessing ceftaroline MIC values of >2 mg/L were identified. The objective of this study was to characterize these four isolates to elucidate the mechanism of ceftaroline resistance. METHODS: MIC determinations were performed using broth microdilution and whole genome sequencing was performed to enable sequence-based analyses. RESULTS: The only changes in proteins known to be required for full expression of methicillin resistance that correlated with the ceftaroline MIC were in penicillin-binding protein 2a (PBP2a). Isolates with a ceftaroline MIC of 2 mg/L had a Glu239Lys mutation in the non-penicillin-binding domain whereas the four isolates with ceftaroline MIC values of 8 mg/L carried an additional Glu447Lys mutation in the penicillin-binding domain. The impact of these mutations was analysed using the known X-ray structure of S. aureus PBP2a and a model for ceftaroline resistance proposed. Analysis of the core genomes showed that the isolates with reduced susceptibility to ceftaroline were epidemiologically related. CONCLUSIONS: Mutations in PBP2a can affect the activity of ceftaroline against MRSA. Although a rare event, based on surveillance studies, it appears a first-step change in the non-penicillin-binding domain together with a second-step in the penicillin-binding domain may result in elevation of the ceftaroline MIC to >2 mg/L.


Subject(s)
Cephalosporins/pharmacology , Drug Resistance, Bacterial/genetics , Methicillin-Resistant Staphylococcus aureus/genetics , Penicillin-Binding Proteins/genetics , Staphylococcal Infections/drug therapy , Amino Acid Substitution , Anti-Bacterial Agents/pharmacology , Bacterial Typing Techniques , Base Sequence , DNA, Bacterial/genetics , Genome, Bacterial/genetics , Humans , Methicillin-Resistant Staphylococcus aureus/drug effects , Methicillin-Resistant Staphylococcus aureus/isolation & purification , Microbial Sensitivity Tests , Models, Molecular , Penicillin-Binding Proteins/ultrastructure , Sequence Analysis, DNA , Staphylococcal Infections/epidemiology , Ceftaroline
8.
Genome Announc ; 1(5)2013 Sep 19.
Article in English | MEDLINE | ID: mdl-24051324

ABSTRACT

Here we report the draft genome sequence of a bloodstream isolate of methicillin-resistant Staphylococcus aureus strain SA16. Strain SA16 is a sequence type 5 (ST5)-staphylococcal cassette chromosome mec type II (SCCmec II) clone and was the most prevalent isolate at a Brazilian hospital during the second half of 2009.

9.
mBio ; 3(3)2012.
Article in English | MEDLINE | ID: mdl-22617140

ABSTRACT

UNLABELLED: Methicillin-resistant Staphylococcus aureus (MRSA) strains are leading causes of hospital-acquired infections in the United States, and clonal cluster 5 (CC5) is the predominant lineage responsible for these infections. Since 2002, there have been 12 cases of vancomycin-resistant S. aureus (VRSA) infection in the United States-all CC5 strains. To understand this genetic background and what distinguishes it from other lineages, we generated and analyzed high-quality draft genome sequences for all available VRSA strains. Sequence comparisons show unambiguously that each strain independently acquired Tn1546 and that all VRSA strains last shared a common ancestor over 50 years ago, well before the occurrence of vancomycin resistance in this species. In contrast to existing hypotheses on what predisposes this lineage to acquire Tn1546, the barrier posed by restriction systems appears to be intact in most VRSA strains. However, VRSA (and other CC5) strains were found to possess a constellation of traits that appears to be optimized for proliferation in precisely the types of polymicrobic infection where transfer could occur. They lack a bacteriocin operon that would be predicted to limit the occurrence of non-CC5 strains in mixed infection and harbor a cluster of unique superantigens and lipoproteins to confound host immunity. A frameshift in dprA, which in other microbes influences uptake of foreign DNA, may also make this lineage conducive to foreign DNA acquisition. IMPORTANCE: Invasive methicillin-resistant Staphylococcus aureus (MRSA) infection now ranks among the leading causes of death in the United States. Vancomycin is a key last-line bactericidal drug for treating these infections. However, since 2002, vancomycin resistance has entered this species. Of the now 12 cases of vancomycin-resistant S. aureus (VRSA), each was believed to represent a new acquisition of the vancomycin-resistant transposon Tn1546 from enterococcal donors. All acquisitions of Tn1546 so far have occurred in MRSA strains of the clonal cluster 5 genetic background, the most common hospital lineage causing hospital-acquired MRSA infection. To understand the nature of these strains, we determined and examined the nucleotide sequences of the genomes of all available VRSA. Genome comparison identified candidate features that position strains of this lineage well for acquiring resistance to antibiotics in mixed infection.


Subject(s)
Cross Infection/microbiology , Methicillin-Resistant Staphylococcus aureus/classification , Methicillin-Resistant Staphylococcus aureus/genetics , Staphylococcal Infections/microbiology , Staphylococcus aureus/classification , Staphylococcus aureus/genetics , Amino Acid Sequence , Bacterial Proteins/chemistry , Bacterial Proteins/genetics , Cross Infection/epidemiology , Genomics , Humans , Methicillin Resistance , Methicillin-Resistant Staphylococcus aureus/drug effects , Methicillin-Resistant Staphylococcus aureus/isolation & purification , Molecular Sequence Data , Phylogeny , Sequence Alignment , Staphylococcal Infections/epidemiology , Staphylococcus aureus/drug effects , Staphylococcus aureus/isolation & purification , United States/epidemiology , Vancomycin Resistance
10.
mBio ; 3(1): e00318-11, 2012.
Article in English | MEDLINE | ID: mdl-22354958

ABSTRACT

The enterococci are Gram-positive lactic acid bacteria that inhabit the gastrointestinal tracts of diverse hosts. However, Enterococcus faecium and E. faecalis have emerged as leading causes of multidrug-resistant hospital-acquired infections. The mechanism by which a well-adapted commensal evolved into a hospital pathogen is poorly understood. In this study, we examined high-quality draft genome data for evidence of key events in the evolution of the leading causes of enterococcal infections, including E. faecalis, E. faecium, E. casseliflavus, and E. gallinarum. We characterized two clades within what is currently classified as E. faecium and identified traits characteristic of each, including variation in operons for cell wall carbohydrate and putative capsule biosynthesis. We examined the extent of recombination between the two E. faecium clades and identified two strains with mosaic genomes. We determined the underlying genetics for the defining characteristics of the motile enterococci E. casseliflavus and E. gallinarum. Further, we identified species-specific traits that could be used to advance the detection of medically relevant enterococci and their identification to the species level.


Subject(s)
Enterococcus/genetics , Evolution, Molecular , Genome, Bacterial , Alleles , Bacterial Proteins/genetics , Bacterial Proteins/metabolism , Cell Wall/genetics , Cell Wall/metabolism , Enterococcus/classification , Enterococcus/pathogenicity , Genetic Loci , Genetic Variation , Gram-Positive Bacterial Infections/microbiology , Host-Pathogen Interactions , Phylogeny , Polysaccharides, Bacterial/genetics , Polysaccharides, Bacterial/metabolism , Species Specificity
11.
Curr Opin Microbiol ; 13(5): 632-9, 2010 Oct.
Article in English | MEDLINE | ID: mdl-20837397

ABSTRACT

Enterococci are Gram-positive bacteria that normally colonize gastrointestinal tracts of humans and animals. They are of growing concern because of their ability to cause antibiotic resistant hospital infections. Antibiotic resistance has been acquired, and has disseminated throughout enterococci, via horizontal transfer of mobile genetic elements. This transmission has been mediated mainly by conjugative plasmids of the pheromone-responsive and broad host range incompatibility group 18 type. Genome sequencing is revealing the extent of diversity of these and other mobile elements in enterococci, as well as the extent of recombination and rearrangement resulting in new phenotypes. Pheromone-responsive plasmids were recently shown to promote genome plasticity in antibiotic resistant Enterococcus faecalis, and their involvement has been implicated in E. faecium as well. Further, incompatibility group 18 plasmids have recently played an important role in mediating transfer of vancomycin resistance from enterococci to methicillin-resistant strains of S. aureus.


Subject(s)
Drug Resistance, Multiple, Bacterial , Enterococcus faecalis/genetics , Gene Transfer, Horizontal , Plasmids/genetics , Vancomycin Resistance/genetics , Anti-Bacterial Agents/pharmacology , Enterococcus faecalis/pathogenicity , Genome, Bacterial , Microbial Sensitivity Tests , Pheromones/pharmacology
12.
Microbiol Mol Biol Rev ; 74(3): 341-62, 2010 Sep.
Article in English | MEDLINE | ID: mdl-20805402

ABSTRACT

Complex glycoconjugates play critical roles in the biology of microorganisms. Despite the remarkable diversity in glycan structures and the bacteria that produce them, conserved themes are evident in the biosynthesis-export pathways. One of the primary pathways involves representatives of the ATP-binding cassette (ABC) transporter superfamily. These proteins are responsible for the export of a wide variety of cell surface oligo- and polysaccharides in both Gram-positive and Gram-negative bacteria. Recent investigations of the structure and function of ABC transporters involved in the export of lipopolysaccharide O antigens have revealed two fundamentally different strategies for coupling glycan polymerization to export. These mechanisms are distinguished by the presence (or absence) of characteristic nonreducing terminal modifications on the export substrates, which serve as chain termination and/or export signals, and by the presence (or absence) of a discrete substrate-binding domain in the nucleotide-binding domain polypeptide of the ABC transporter. A bioinformatic survey examining ABC exporters from known oligo- and polysaccharide biosynthesis loci identifies conserved nucleotide-binding domain protein families that correlate well with themes in the structures and assembly of glycans. The familial relationships among the ABC exporters generate hypotheses concerning the biosynthesis of structurally diverse oligo- and polysaccharides, which play important roles in the biology of bacteria with different lifestyles.


Subject(s)
ATP-Binding Cassette Transporters/chemistry , Glycoconjugates/metabolism , ATP-Binding Cassette Transporters/genetics , ATP-Binding Cassette Transporters/metabolism , Animals , Cell Membrane/metabolism , Computational Biology , Humans , Models, Biological , Phylogeny , Receptors, Cell Surface/chemistry , Receptors, Cell Surface/metabolism
13.
J Biol Chem ; 285(25): 19668-87, 2010 Jun 18.
Article in English | MEDLINE | ID: mdl-20410291

ABSTRACT

D-galactan I is a polysaccharide with the disaccharide repeat unit structure [-->3-beta-D-Galf-(1-->3)-alpha-D-Galp-(1-->]. This glycan represents the lipopolysaccharide O antigen found in many Gram-negative bacteria, including several Klebsiella pneumoniae O serotypes. The polysaccharide is synthesized in the cytoplasm prior to its export via an ATP-binding cassette transporter. Sequence analysis predicts three galactosyltransferases in the D-galactan I genetic locus. They are WbbO (belonging to glycosyltransferase (GT) family 4), WbbM (GT-family 8), and WbbN (GT-family 2). The WbbO and WbbM proteins are each predicted to contain two domains, with the GT modules located toward their C termini. The N-terminal domains of WbbO and WbbM exhibit no similarity to proteins with known function. In vivo complementation assays suggest that all three glycosyltransferases are required for D-galactan I biosynthesis. Using a bacterial two-hybrid system and confirmatory co-purification strategies, evidence is provided for protein-protein interactions among the glycosyltransferases, creating a membrane-located enzyme complex dedicated to d-galactan I biosynthesis.


Subject(s)
Galactans/chemistry , Klebsiella pneumoniae/metabolism , O Antigens/chemistry , ATP-Binding Cassette Transporters/chemistry , Amino Acid Sequence , Cell Membrane/metabolism , Lipopolysaccharides/chemistry , Molecular Sequence Data , Polymers/chemistry , Polysaccharides/chemistry , Protein Structure, Secondary , Protein Structure, Tertiary , Sequence Analysis, DNA , Subcellular Fractions/metabolism , Two-Hybrid System Techniques
14.
Cell Mol Life Sci ; 66(19): 3111-26, 2009 Oct.
Article in English | MEDLINE | ID: mdl-19544044

ABSTRACT

The ATP-binding cassette family is one of the largest groupings of membrane proteins, moving allocrites across lipid membranes, using energy from ATP. In bacteria, they reside in the inner membrane and are involved in both uptake and export. In eukaryotes, these transporters reside in the cell's internal membranes as well as in the plasma membrane and are unidirectional-out of the cytoplasm. The range of substances that these proteins can transport is huge, which makes them interesting for structure-function studies. Moreover, their abundance in nature has made them targets for structural proteomics consortia. There are eight independent structures for ATP-binding cassette transporters, making this one of the best characterised membrane protein families. Our understanding of the mechanism of transport across membranes and membrane protein structure in general has been enhanced by recent developments for this family.


Subject(s)
ATP-Binding Cassette Transporters/chemistry , ATP-Binding Cassette Transporters/physiology , Adenosine Triphosphate/metabolism , Amino Acid Sequence , Binding Sites , Conserved Sequence , Hydrolysis , Lipid Bilayers/chemistry , Models, Molecular , Protein Structure, Tertiary , Structure-Activity Relationship
15.
J Biol Chem ; 284(5): 2947-2956, 2009 Jan 30.
Article in English | MEDLINE | ID: mdl-19036729

ABSTRACT

An ATP-binding cassette (ABC) transporter-dependent mechanism is responsible for the biosynthesis of polysaccharide O antigens in the lipopolysaccharides of many Gram-negative bacteria. In the Escherichia coli O9a prototype, addition of a non-reducing terminal modification regulates chain length. The terminal residue is an export signal recognized by the nucleotide-binding domain component of the cognate ABC transporter. The Klebsiella pneumoniae O2a antigen lacks a capping residue, and the corresponding nucleotide-binding protein does not contain a separate substrate-binding domain. Unlike the O9a transporter, the O2a transporter can export heterologous O antigens. Export of the O2a antigen is obligatorily coupled to chain elongation, and the O2a transporter is essential for establishing O antigen chain length. The E. coli O9a transporter operates after chain length has been determined. Furthermore biosynthesis and export can be uncoupled. O antigen chain length is a critical element in the ability of lipopolysaccharides to confer resistance to complement-mediated killing. This study establishes that two distinctly different approaches are available for the regulation of O antigen chain length and export via an ABC transporter.


Subject(s)
ATP-Binding Cassette Transporters/physiology , Klebsiella pneumoniae/immunology , O Antigens/immunology , ATP-Binding Cassette Transporters/chemistry , Amino Acid Sequence , Carbohydrate Sequence , Microscopy, Fluorescence , Molecular Sequence Data , Sequence Homology, Amino Acid
16.
Res Microbiol ; 157(6): 503-7, 2006.
Article in English | MEDLINE | ID: mdl-16500085

ABSTRACT

This study describes the approach used to verify the species identity of 23 erythromycin-resistant Campylobacter isolates whose identity was initially determined based mainly on the results of the rapid hippurate hydrolysis test or the results of the API-Campy identification system. Species identification of the isolates investigated was confirmed by repeating hippurate hydrolysis using a modification of the rapid hydrolysis test, in addition to performing three genetic-based assays. The original identification was verified in 69.6% of the isolates. The remaining isolates showed discrepancies in identity as determined by results of the identification assays performed. A duplex PCR assay, targeting the hipO and aspA genes, indicated the existence of mixed cultures of C. jejuni and C. coli in the frozen stocks of two of these isolates.


Subject(s)
Anti-Bacterial Agents/pharmacology , Campylobacter coli/classification , Campylobacter coli/drug effects , Campylobacter jejuni/classification , Campylobacter jejuni/drug effects , Drug Resistance, Bacterial/physiology , Erythromycin/pharmacology , Bacterial Typing Techniques , Campylobacter coli/isolation & purification , Campylobacter jejuni/isolation & purification , DNA Primers , Microbial Viability , Polymerase Chain Reaction , Species Specificity
17.
Antimicrob Agents Chemother ; 50(2): 778-80, 2006 Feb.
Article in English | MEDLINE | ID: mdl-16436744

ABSTRACT

One hundred four isolates of Campylobacter jejuni from poultry in Alberta, Canada, collected during 2001 were tested for resistance to 10 antimicrobial agents using agar dilution. This study provides a baseline of resistance profiles and the mechanisms of resistance observed in C. jejuni in poultry from Alberta, Canada.


Subject(s)
Campylobacter jejuni/drug effects , Poultry/microbiology , Animals , Drug Resistance, Bacterial , Microbial Sensitivity Tests
18.
Antimicrob Agents Chemother ; 49(7): 2753-9, 2005 Jul.
Article in English | MEDLINE | ID: mdl-15980346

ABSTRACT

A collection of 23 macrolide-resistant Campylobacter isolates from different geographic areas was investigated to determine the mechanism and stability of macrolide resistance. The isolates were identified as Campylobacter jejuni or Campylobacter coli based on the results of the hippurate biochemical test in addition to five PCR-based genotypic methods. Three point mutations at two positions within the peptidyl transferase region in domain V of the 23S rRNA gene were identified. About 78% of the resistant isolates exhibited an A-->G transition at Escherichia coli equivalent base 2059 of the 23S rRNA gene. The isolates possessing this mutation showed a wide range of erythromycin and clarithromycin MICs. Thus, this mutation may incur a greater probability of treatment failure in populations infected by resistant Campylobacter isolates. Another macrolide-associated mutation (A-->C transversion), at E. coli equivalent base 2058, was detected in about 13% of the isolates. An A-->G transition at a position cognate with E. coli 23S rRNA base 2058, which is homologous to the A2142G mutation commonly described in Helicobacter pylori, was also identified in one of the C. jejuni isolates examined. In the majority of C. jejuni isolates, the mutations in the 23S rRNA gene were homozygous except in two cases where the mutation was found in two of the three copies of the target gene. Natural transformation demonstrated the transfer of the macrolide resistance phenotype from a resistant Campylobacter isolate to a susceptible Campylobacter isolate. Growth rates of the resulting transformants containing A-2058-->C or A-2059-->G mutations were similar to that of the parental isolate. The erythromycin resistance of six of seven representative isolates was found to be stable after successive subculturing in the absence of erythromycin selection pressure regardless of the resistance level, the position of the mutation, or the number of the mutated copies of the target gene. One C. jejuni isolate showing an A-2058-->G mutation, however, reverted to erythromycin and clarithromycin susceptibility after 55 subcultures on erythromycin-free medium. Investigation of ribosomal proteins L4 and L22 by sequence analysis in five representative isolates of C. jejuni and C. coli demonstrated no significant macrolide resistance-associated alterations in either the L4 or the L22 protein that might explain either macrolide resistance or enhancement of the resistance level.


Subject(s)
Anti-Bacterial Agents/pharmacology , Campylobacter coli/drug effects , Campylobacter jejuni/drug effects , Drug Resistance, Bacterial/genetics , Macrolides/pharmacology , Animals , Campylobacter coli/genetics , Campylobacter coli/growth & development , Campylobacter jejuni/genetics , Campylobacter jejuni/growth & development , Cattle , Erythromycin/pharmacology , Humans , Microbial Sensitivity Tests , Point Mutation , RNA, Ribosomal, 23S/genetics , Transformation, Bacterial
SELECTION OF CITATIONS
SEARCH DETAIL
...